|
|
Isabella Tai
Switch to Isabella T. Tai's research page...
Selected Publications
2008
Chan SK, Griffith OL, Tai IT, Jones SJ.
Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers
Cancer Epidemiol Biomarkers Prev
(2008).
[View Abstract - PubMed 18349271 ] Request Paper
Cheetham S, Tang MJ, Mesak F, Kennecke H, Owen D, Tai IT.
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Br J Cancer
(2008).
[View Abstract - PubMed 18458674 ] Request Paper
Griffith M, Tang MJ, Griffith OL, Morin RD, Chan SY, Asano JK, Zeng T, Flibotte S, Ally A, Baross A, Hirst M, Jones SJ, Morin GB, Tai IT, Marra MA.
ALEXA: a microarray design platform for alternative expression analysis.
Nat Methods
(2008).
[View Abstract - PubMed 18235430 ] Request Paper
2007
Taghizadeh F, Tang MJ, Tai IT.
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy.
Mol Cancer Ther.
(2007). Request Paper
Tang MJ, Tai IT.
A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers.
J Biol Chem
(2007).
[View Abstract - PubMed 17897953] Request Paper
2005
Tai IT, Dai M, Chen LB.
Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies.
Carcinogenesis.
(2005). Request Paper
Tai IT, Dai M, Owen DA, Chen LB.
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy.
J Clin Invest.
(2005). Request Paper
2003
Davies FE, Dring AM, Li C, Rawstron AC, Shammas MA, O'Connor SM, Fenton JA, Hideshima T, Chauhan D, Tai IT, Robinson E, Auclair D, Rees K, Gonzalez D, Ashcroft AJ, Dasgupta R, Mitsiades C, Mitsiades N, Chen LB, Wong WH, Munshi NC, Morgan GJ, Anderson KC.
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.
Blood
(2003). Request Paper
URL: http://www.bccrc.ca/gsc/pubs_itai.html
The BC Cancer Agency Research Centre is the research arm of the BC Cancer Agency (BCCA), and is supported by the BC Cancer Foundation.
This page was last modified at 11:34am on July 8, 2008
© 1999-2008.
BC Cancer Agency. All rights reserved.
About this website...
|
|
|
|
Navigation Menu
View Site Map
Contact Us
BC Cancer Agency Research Centre
675 West 10th Avenue
Vancouver, BC
V5Z 1L3 Canada
1-604-675-8000
| |
|